Your Cinnamon Has a Cheaper Twin, and Your Blood Sugar Might Notice

The Oasis Health Journal · Submitted July 8, 2026 · 11:16 AM ET

There are two spices in your kitchen answering to the same name, and they are not as related as you would guess. Ceylon cinnamon is the quiet one from Sri Lanka that botanists call the 'true' cinnamon. Cassia is the loud one in the grocery jar, the cinnamon in your oatmeal, your gum, and roughly every cinnamon roll you have ever regretted. Same name, different tree. The National Center for Complementary and Integrative Health notes that cassia is the type most commonly sold in North America, which means the cinnamon in your cabinet is probably not the cinnamon the interesting studies keep talking about.

This is more than a trivia-night footnote, because cinnamon has spent two decades auditioning for a supporting role in blood sugar, and the casting notes are finally getting specific.

What the newest trial actually did

In January 2025, a randomized, double-blind, controlled trial in PLOS ONE handed 150 adults a standardized Ceylon cinnamon extract. Not the powder from the jar. An extract, tuned to at least 30 percent polyphenols (mostly type A proanthocyanidins), with a coumarin content of 0.01 percent. Hold onto that last number.

The Ceylon group saw fasting blood sugar fall by about 8.6 mg/dL more than placebo, a real and statistically significant gap, though not a fireworks show. The better part was hiding in the subgroup. Participants who actually had type 2 diabetes saw a much larger drop, while their LDL cholesterol basically shrugged and stayed where it was. So the honest headline is not 'cinnamon fixes everything.' It is closer to 'a specific Ceylon extract nudged fasting glucose, and nudged it hardest in the people with the most room to move.'

Zoom out, and the picture gets blurrier

Pool the older trials and the signal survives, but it wobbles. An umbrella review of previous meta-analyses found cinnamon lowered fasting plasma glucose by roughly 10.9 mg/dL and shaved HbA1c by about 0.10 percent. A separate dose-response meta-analysis in Phytotherapy Research agreed that cinnamon significantly reduced both fasting glucose and HbA1c in people with type 2 diabetes. Modest, but present, and pointed in the right direction.

Here is the part the supplement ads leave in the footnotes. NCCIH, looking at the entire pile, says the research does not clearly support cinnamon for any health condition, partly because many of the studies never bothered to record which species or plant part they used. A 2018 review in Clinical Pharmacology and Therapeutics made the same complaint, calling the cinnamon-versus-cassia mix-up a genuine threat to how usable the clinical data even is. Picture a stack of driving studies that forgot to note whether people were in cars or on bicycles. That is the cinnamon literature. The effect looks real and small, and the fog around it is large.

The twist that lives in your liver

Now back to that coumarin number. Coumarin is a compound in cassia that is hepatotoxic in a dose-dependent and slightly unpredictable way, which is why the European Food Safety Authority set a tolerable daily intake of just 0.1 mg per kilogram of body weight. Germany's risk agency, the BfR, plainly recommends eating high-coumarin cassia in moderation. Cassia can carry a serious amount of it. Ceylon carries only a trace, a point NCCIH confirms.

Sprinkle cassia on a latte once in a while and this is a non-issue. But blood sugar experiments are not once-in-a-while affairs. They run for weeks to months, gram by gram. At that pace the species you picked stops being a flavor preference and starts being a liver decision. That is the whole case for Ceylon in a single line: similar job, far less coumarin. Your liver keeps better records than you do.

The unglamorous fine print

Cinnamon is a seasoning with a modest metabolic hobby, not a medication. It does not replace metformin, insulin, or the daily blood sugar support formulas people actually build routines around, and if you already take glucose-lowering drugs, adding a supplement on top is a conversation for your clinician, not a thing to freestyle. If you want to explore the category, start with genuine Ceylon cinnamon rather than mystery-species powder. Some people also compare notes with berberine or alpha-lipoic acid, each carrying its own separately messy research story.

One note on potency, since it is the entire point here. Botanical actives fade as they sit, so a jar that aged in a warehouse is quietly weaker than its label promises. We source professional-grade product fresh per order instead of parking inventory on a shelf, which makes shipping a little slower and the thing inside the bottle a little more alive. For a compound whose whole value is a small, dose-dependent effect, fresher is not a flourish. It is the difference between doing something and doing nothing.

Two trees, one name. Pick the one that read the study.

This article is for education only and is not medical advice, diagnosis, or treatment. Talk with a qualified healthcare professional before changing your supplement routine, especially if you manage diabetes or take glucose-lowering medication.

Sources

1. Effects of Cinnamomum zeylanicum (Ceylon cinnamon) extract on lipid profile, glucose levels and its safety in adults: a randomized, double-blind, controlled trial. PLOS ONE, January 2025.
2. The effect of cinnamon supplementation on glycemic control in type 2 diabetes or PCOS: an umbrella meta-analysis of interventional meta-analyses. Diabetology and Metabolic Syndrome, 2023.
3. The effect of cinnamon supplementation on glycemic control in type 2 diabetes: an updated systematic review and dose-response meta-analysis of randomized controlled trials. Phytotherapy Research, 2023.
4. Cinnamon: Usefulness and Safety. NIH National Center for Complementary and Integrative Health, 2024.
5. Oketch-Rabah HA, Marles RJ, Brinckmann JA. Cinnamon and cassia nomenclature confusion: a challenge to the applicability of clinical data. Clinical Pharmacology and Therapeutics, 2018.
6. Cassia cinnamon with high coumarin contents to be consumed in moderation. German Federal Institute for Risk Assessment (BfR).